Troubling Drug Developments in the News
December 1, 2009 No CommentsZETIA: LOWERS CHOLESTEROL BUT DOESN’T LOWER RISK Ezetemibe (Zetia, Vytorin) remains a favorite cholesterol lowering drug in spite of the fact that research has yet to show it prevents heart attacks and may increase risk of cancer. Approximately 24 million prescriptions were written out by doctors in 2008. A month’s worth of this questionable drug ...
Weekly Health Bulletins
